Company Filing History:
1 out of 24 
1 out of 4,456 
1 out of 832,912 Years Active: 1998-2015
Title: David Chianese: Innovator in Cancer Detection and Treatment Technology
Introduction
David Chianese is an accomplished inventor based in Ardmore, Pennsylvania, who has made significant contributions to the fields of cancer detection and treatment technology. With two patents to his name, his innovative approaches address critical needs in medical diagnostics and treatment regimens.
Latest Patents
Chianese's latest patents reflect his commitment to advancing healthcare technology. The first patent is for a "Circulating Tumor Cell Assay," which describes methods for detecting, enumerating, and analyzing circulating tumor cells expressing insulin-like growth factor-1 receptors (IGF-1R). These methods are not only pivotal for cancer screening and staging, but also for the development of treatment regimens and monitoring treatment responses, including cancer recurrence. Furthermore, the patent includes test kits designed to facilitate the detection and analysis of such tumor cells.
Another notable patent is for a "Reagent Strip Slide Treating Apparatus." This invention features a reagent strip comprised of multiple chambers connected by a reagent passageway to a common passageway. Designed for biological material treatment, the apparatus allows sequential application of a variety of reagents through capsules that burst upon pressure, ensuring precise timing and efficacy during the treatment process. This innovative design enhances the efficiency and accuracy of laboratory testing.
Career Highlights
Throughout his career, David Chianese has contributed to significant advancements in the medical technology sector through his work. He has held positions at reputable companies, including Veridex, LLC, where his expertise in cancer diagnostics has been instrumental in developing cutting-edge solutions that aim to improve patient outcomes.
Collaborations
Chianese has collaborated with notable colleagues in his field, including Antonio Gualberto and Maria Luisa Paccagnella. These partnerships have likely contributed to the successful development of his patented technologies, demonstrating the importance of teamwork in fostering innovation.
Conclusion
David Chianese exemplifies the spirit of innovation, with his work leading to advancements that have the potential to significantly impact cancer screening and treatment. His patents not only underline his ingenuity but also exemplify the collaborative nature of research and development in healthcare technology, where collective knowledge and expertise drive progress toward better medical solutions.